This study was focused on understanding the mechanism cells use to adapt to proteotoxic stress. Part of the work used a panel of 549 PRISM cell lines grown in either glucose or galactose (to increase dependency on mitochondrial metabolism) in the presence or absence of bortezomib. Increased mitochondrial metabolism promoted proteasome inhibitor resistance.
PRISM will be accepting submissions for our next screen
January 27 – February 14, 2025!
This screen will be for DMSO-soluble small molecules only against the PRISM collection of 930 cancer cell lines.